List of works - Joanna Szarmach

Benzodiazepines as adjunctive therapy in treatment refractory symptoms of schizophrenia

scientific article

Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy

scientific article

Different Faces of Neurosyphilis

scientific article published on 01 July 2018

Diverse clinical presentations of neurosyphilis: focus on differential diagnosis.

scientific article published on 27 November 2017

Efficacy of Ketamine in bipolar depression: focus on anhedonia

scientific article published on 01 September 2019

Lithium therapeutic dose monitoring in human saliva

scientific article published in September 2017

Magnesium and ketamine in the treatment of depression

scientific article published on 01 September 2019

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

scientific article published on 29 October 2020

Neurosyphilis - the white matter disintegration? - two case reports

scientific article published in September 2017

Neurosyphilis presenting with cognitive deficits - a report of two cases

scientific article published in September 2017

Neurosyphilis: a masked evildoer

scientific article published on 01 December 2018

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study.

scientific article published on April 2017

Role of copper and ketamine in major depressive disorder - an update

scientific article published on 01 September 2019

Short-term ketamine administration in treatment-resistant depression patients: focus on adverse effects on the central nervous system

scientific article published on 01 September 2019

Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety

scientific article published on 01 September 2019

Suicidality in treatment resistant depression: perspective for ketamine use

scientific article published on 01 September 2019

Telepsychiatry and Virtual Reality an the Teatment of Patients with Intellectual and Developmental Disabilities

scientific article

The Role of Hormones and Inflammatory Markers in Cognitive Functioning of Schizophrenic Patients

scientific article published in September 2017

The immunomodulatory effect of ketamine in depression

scientific article published on 01 September 2019

What really is a 'gold standard' in depression recognition among patients with epilepsy?

scientific article published on 19 July 2018

List of works by Joanna Szarmach

Benzodiazepines as adjunctive therapy in treatment refractory symptoms of schizophrenia

Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy

Different Faces of Neurosyphilis

Diverse clinical presentations of neurosyphilis: focus on differential diagnosis.

Efficacy of Ketamine in bipolar depression: focus on anhedonia

Lithium therapeutic dose monitoring in human saliva

Magnesium and ketamine in the treatment of depression

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

Neurosyphilis - the white matter disintegration? - two case reports

Neurosyphilis presenting with cognitive deficits - a report of two cases

Neurosyphilis: a masked evildoer

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study.

Role of copper and ketamine in major depressive disorder - an update

Short-term ketamine administration in treatment-resistant depression patients: focus on adverse effects on the central nervous system

Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety

Suicidality in treatment resistant depression: perspective for ketamine use

Telepsychiatry and Virtual Reality an the Teatment of Patients with Intellectual and Developmental Disabilities

The Role of Hormones and Inflammatory Markers in Cognitive Functioning of Schizophrenic Patients

The immunomodulatory effect of ketamine in depression

What really is a 'gold standard' in depression recognition among patients with epilepsy?